Tumorigenicity of EGFR- and/or HER2-Positive Breast Cancers Is Mediated by Recruitment of Tumor-Associated Macrophages
Daeun You(Samsung (South Korea)), Jeong Eon Lee(Seoul National University)
Cited by 10
Related Papers
Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction
|Oncotarget|2016|57
Celastrol attenuates the inflammatory response by inhibiting IL‑1β expression in triple‑negative breast cancer cells
|Oncology Reports|2021|38
Zerumbone suppresses EGF-induced CD44 expression through the inhibition of STAT3 in breast cancer cells
|Oncology Reports|2014|30
Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells
|BMB Reports|2017|27
Wild-type p53 controls the level of fibronectin expression in breast cancer cells
|Oncology Reports|2017|9